Study guide

21.2 Regulatory Agencies, Review Contractors and Appeals

AHIMA Certified Documentation Integrity Practitioner CDIP

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Authoritative Coding Resources & Conventions

1.1 Official Coding Resources: Scope, Authority & Research 1.2 General Coding Conventions, Punctuation & Instructional Notes 1.3 Chapter-Specific and Setting-Specific Coding Guidelines

2 Chapter 2: Principal & Secondary Diagnosis Determination

2.1 UHDDS Definitions & Principal Diagnosis Selection 2.2 Two or More Diagnoses Equally Meeting Criteria 2.3 Secondary Diagnosis Reporting Standards & POA Status

3 Chapter 3: Procedure Coding & Sequencing Standards

3.1 ICD-10-PCS Root Operations & Inpatient Procedure Coding 3.2 Principal Procedure Selection & Surgical Sequencing 3.3 Applying Official References to Ambiguous Records

4 Chapter 4: Inpatient Prospective Payment & DRG Grouping

4.1 MS-DRG Logic, CC/MCC Exclusions & Severity Levels 4.2 Working vs. Final DRG Assignment & Optimization vs. Maximization 4.3 CDI-Coding Reconciliation & Annual Regulatory Updates

5 Chapter 5: Enterprise CDI Promotion & Program Value

5.1 Articulating CDI Value to C-Suite & Hospital Leadership 5.2 Organizational Models, Inpatient/Outpatient Scope & Staffing 5.3 Cross-Functional Collaboration: HIM, Quality & Case Management

6 Chapter 6: Cross-Functional Alignment & Improvement Projects

6.1 Partnering with Nursing, Pharmacy & Allied Health Professionals 6.2 Documentation Improvement Project Identification & Scoping 6.3 Executing, Piloting & Measuring CDI Project Outcomes

7 Chapter 7: Physician Champion Engagement & Clinical Advocacy

7.1 Selection, Role & Credibility of the CDI Physician Champion 7.2 Peer-to-Peer Engagement, Coaching & Overcoming Resistance 7.3 Developing Standard CDI Operational Policies & Procedures

8 Chapter 8: Compliant Policy Architecture & Query Governance

8.1 AHIMA/ACDIS Practice Brief Standards in Policy Construction 8.2 Medical Record Integration of Provider Query Responses 8.3 Policies for Electronic, Paper, and Verbal Query Communications

9 Chapter 9: Query Escalation & Professional Communication

9.1 Chain of Command & Protocols for Unanswered Queries 9.2 Conflict Resolution & Professional Feedback Mechanisms 9.3 Assessing Stakeholder Learning Needs & Specialty Curricula

10 Chapter 10: Educational Delivery & Broader Healthcare Impacts

10.1 Delivery Methods: Microlearning, Case Studies & Grand Rounds 10.2 Documentation Impacts on Clinical Research & Epidemiology 10.3 Documentation Impacts on Case Management, LOS & Reimbursement

11 Chapter 11: Clinical Record Synthesis & Encounter Trajectory

11.1 Synthesizing Provider Notes, Consults & Progress Trajectory 11.2 Interpreting Diagnostic Imaging, Pathology & Labs 11.3 Resolving Conflicting, Ambiguous & Copy-Forward Entries

12 Chapter 12: Advanced Clinical Concepts & Review Prioritization

12.1 Pharmacotherapy, Clinical Trajectories & Disease Correlations 12.2 Inpatient Review Prioritization: High-Risk & High-Volume 12.3 Payer Prioritization, Length of Stay & Re-Review Cadence

13 Chapter 13: Clinical Indicator Mapping & Gap Recognition

13.1 Systematic Identification of Documentation Gaps 13.2 Sepsis Definitions, SEP-1, and Coding 13.3 AKI Criteria, Tubular Injury, and CKD Staging

14 Chapter 14: Diagnostic Precision in High-Impact Conditions

14.1 Respiratory Failure: Acuity, Evidence, and Sequencing 14.2 Heart Failure Phenotype, Acuity, and Hypertensive Combinations 14.3 Encephalopathy, Delirium, and Acute Cognitive Change

15 Chapter 15: Clinical Validation & Complication Discrepancies

15.1 Malnutrition Assessment, Severity, and Provider Documentation 15.2 Principles of a Compliant, Nonleading Query 15.3 Open-Ended, Multiple-Choice, and Yes/No Queries

16 Chapter 16: Query Mechanics & Direct Provider Collaboration

16.1 Electronic Query Systems, Templates, and Technology Oversight 16.2 Collaborating With the Appropriate Query Recipient 16.3 Capturing and Clarifying Query Responses

17 Chapter 17: Quality Indicators & Post-Discharge Clarification

17.1 Present on Admission Clarification and Selected HAC Rules 17.2 Clarifying Acuity, Cause, Site and Severity 17.3 Post-Discharge Query Opportunities and Limits 17.4 Managing Post-Discharge Query Workflows

18 Chapter 18: CDI Operational Dashboards & Quality Auditing

18.1 Departmental Metrics: Definitions, Calculations and Dashboard Use 18.2 Internal CDI Quality Audits and Reviewer Calibration 18.3 Query Trends: Understanding the Process and Provider Experience

19 Chapter 19: Benchmarking, Productivity & Data-Driven Workflow

19.1 Provider Documentation Benchmarking 19.2 External Benchmarking: CMI, Severity, Mortality and Length of Stay 19.3 Evaluating CDI Professional Performance 19.4 Using Data to Design CDI Workflow and Staffing

20 Chapter 20: Ethical CDI Standards & Regulatory Frameworks

20.1 Applying AHIMA Ethics to CDI Decisions 20.2 Responding to Financial Pressure and Upcoding Risks 20.3 Maintaining Competence and Professional Integrity

21 Chapter 21: Regulatory Compliance & Enforcement Landscapes

21.1 False Claims, Overpayments and Referral Laws 21.2 Regulatory Agencies, Review Contractors and Appeals 21.3 EHR Templates, Copied Text and Record Integrity

22 Chapter 22: Technology Risks & Second-Level Review Protocols

22.1 CAC, NLP and AI: Context, Oversight and Performance 22.2 Selecting Cases for Second-Level Review 22.3 Conducting and Closing a Second-Level Review

23 Chapter 23: Clinical Validation Queries & Risk Mitigation

23.1 Clinical Validation and Coding Clarification 23.2 Clinical Validation Queries and Denial Evidence 23.3 Detecting Leading, Biased and Unsupported Queries

24 Chapter 24: Noncompliant Query Remediation & Query Lifecycle Management

24.1 Query Remediation and Corrective Action 24.2 Query Timeframes, Aging and Measurement 24.3 Query Records, Retention and Evidence Preservation

21.2 Regulatory Agencies, Review Contractors and Appeals

Key Takeaways Explain This Topic AI

Identify the actual process and notice: claim review, survey, investigation, quality review and appeal have different purposes and authorities.

UPIC investigation and recommendation do not replace CMS approval and MAC implementation of a payment suspension or law-enforcement authority.

Use the current OIG project or report in its stated scope; a CIA is agreement-specific, and an exclusion check is a separate compliance process.

TPE generally uses 20–40 claims per round and up to three rounds, with a low-biller approach that can use fewer claims; it is not a universal three-round guarantee.

Original Medicare A/B claim appeals ordinarily proceed through MAC, QIC, OMHA, Council and court; CY2026 ALJ and court thresholds are $200 and $1,960. Submit evidence early and apply the specific good-cause rules and exceptions to later OMHA evidence.

Last updated: October 2026

Regulatory Agencies, Review Contractors and Appeals

A documentation problem can lead to several different processes: a claim review, a quality-of-care review, a survey, an investigation or an appeal. Identify the process before deciding how to respond. A request for records does not establish fraud, and a contractor's name does not tell you that every action it takes has the same authority or appeal route.

Match the organization to its function

Organization or contractor Main function relevant to CDI Practical response

CMS Administers Medicare, establishes program requirements and oversees contractors Identify the applicable program, regulation, policy and effective date

Medicare Administrative Contractor (MAC) Processes claims, conducts medical review and education, and performs first-level claim redeterminations Follow the specific request or determination; preserve the record, submission evidence and deadlines

Recovery Audit Contractor (RAC) Conducts automated and complex post-payment reviews to identify and correct improper payments, including overpayments and underpayments Check the approved review topic, requested records and findings; distinguish a discussion opportunity from a formal appeal

Unified Program Integrity Contractor (UPIC) Investigates potential fraud, waste and abuse and coordinates appropriate administrative actions and referrals Route the request promptly to the authorized organizational response team; preserve relevant evidence

HHS Office of Inspector General (OIG) Conducts oversight audits and investigations and exercises applicable exclusion and other enforcement authorities Read the actual report or action; involve compliance and counsel as appropriate

Beneficiary and Family Centered Care QIO (BFCC-QIO) Handles quality-of-care concerns and specified beneficiary discharge or service-termination reviews, as well as assigned utilization reviews Use the notice and program-specific instructions; beneficiary fast appeals differ from routine provider claim appeals

CMS describes RAC automated reviews as system-level reviews and complex reviews as reviews requiring a qualified person to examine the medical record. A complex review may involve an Additional Documentation Request (ADR). Neither an ADR nor an unusual billing pattern is itself a final finding of an improper claim. Review the current contractor instructions for compensation, record-request limits and program lookback periods. Reopening authority has separate conditions; a historical RAC limit is not a universal statutory three-year rule. CMS Recovery Audit Program ; 42 CFR §405.980

Keep investigation and enforcement powers distinct

UPIC work can include medical-record requests, medical review, provider contacts and site visits. Its role is broader than simply detecting a particular code error, but it is not a police agency with independent authority to execute a search warrant or issue a criminal indictment. CMS's Program Integrity Manual distinguishes contractor personnel from law-enforcement personnel and describes referrals and coordination. A potential fraud lead is an allegation to investigate, not a completed legal conclusion.

Payment suspension illustrates the division of responsibility. The manual requires referral of payment-suspension requests to CMS for approval. The UPIC coordinates an approved suspension with the MAC, which implements the payment action. A stem saying that a UPIC investigated a suspicious pattern is different from one saying that the contractor independently imposed an unrestricted sanction. Read the notice, authority and procedural stage. CMS Program Integrity Manual, Chapter 4, especially §§4.6–4.7.1 ; Chapter 8, §8.3

Translate oversight findings into accurate local work

OIG's Work Plan helps an organization identify areas warranting attention. Check a project's actual scope and status, then read any resulting report. A report about one population, period or sample does not create a universal diagnostic threshold or establish that the same error occurred in every hospital. A risk signal should guide investigation and education without predetermining provider answers. OIG Work Plan

For example, a malnutrition audit requires separate checks of the provider's diagnosis, clinical support, query process and code assignment. In FY2027 ICD-10-CM, E40 identifies kwashiorkor; E43 identifies unspecified severe protein-calorie malnutrition . They are not interchangeable names. A dietitian's findings can support appropriate clarification but do not automatically substitute for the provider's diagnosis. Evaluate the actual case rather than importing a conclusion from an unrelated audit. FY2027 ICD-10-CM guidelines ; FY2027 Index and Tabular files

A Corporate Integrity Agreement (CIA) is a specific agreement between OIG and an entity. OIG describes a five-year compliance period and obligations such as compliance leadership, training, independent review and reporting, with requirements tailored to the agreement. Not every False Claims Act matter results in a CIA, and a CIA does not universally mandate a particular copy-paste restriction or query sample. Read the signed agreement before describing its obligations. OIG Corporate Integrity Agreements

Exclusion is a separate enforcement concept. OIG's List of Excluded Individuals/Entities (LEIE) identifies current exclusions. Federal health care programs generally cannot pay for items or services furnished, ordered or prescribed by excluded individuals or entities, including specified indirect payment situations. An exclusion check is not the same as a clinical documentation audit, and a coding mistake does not automatically produce exclusion. Route a possible match through the organization's verification and compliance process. OIG Exclusions Program

Understand targeted review and education

Targeted Probe and Educate (TPE) is a MAC review and education process directed at selected risks. CMS generally describes rounds of 20–40 claims with individualized education and up to three rounds; its current low-biller approach can use fewer than 20 claims. Do not interpret these figures as a requirement that every hospital undergo exactly three rounds or as a guarantee against other review. If errors persist, CMS determines possible further action, which may include more intensive review or referral. CMS TPE

The review assignment can change without changing the underlying coverage rule. CMS transferred hospital short-stay patient-status reviews to MACs effective September 1, 2025, using TPE. BFCC-QIOs continue their other assigned functions, including quality concerns, discharge/service-termination appeals and higher-weighted DRG reviews. Do not send records to a former reviewer simply because an old policy names it. CMS hospital patient-status review FAQs, transition and TPE sections

Follow the correct appeal route

The following sequence applies to Original Medicare Parts A and B claim appeals . It is not the universal sequence for Medicare Advantage, commercial contracts, exclusions or beneficiary fast appeals. A provider-payment dispute and a beneficiary coverage appeal may also have different standing and procedures. Start with the actual determination and notice. CMS Parts A and B appeals booklet

Level Review body Ordinary request deadline after receipt of the preceding determination or decision Amount in controversy

  • 1 MAC redetermination 120 calendar days after the initial determination No minimum
  • 2 QIC reconsideration 180 calendar days after the redetermination No minimum

3 OMHA: ALJ hearing or an authorized attorney-adjudicator disposition 60 calendar days after the reconsideration For ALJ hearing requests filed in 2026: at least $200

4 Medicare Appeals Council 60 calendar days after the OMHA decision No minimum

5 U.S. District Court 60 calendar days after the Council decision or order For judicial-review requests filed in 2026: at least $1,960, with other jurisdictional requirements

The amounts are annual thresholds tied to the filing year , not the discharge year. Dismissal-review requests and escalation because an adjudicator has not acted have specific rules that differ from the ordinary table. Receipt is generally presumed five days after the notice date unless evidence shows otherwise; late filing requires the applicable good-cause review. Calendar the notice's instructions rather than treating the table as an extension. CMS CY2026 threshold notice

Adjudication periods are different from filing deadlines. CMS generally describes 60 days for MAC and QIC decisions and 90 days for ordinary OMHA and Council review, subject to applicable extensions and procedural circumstances. Escalated cases can have different periods, including 180 days. Expiration may create an escalation option under the relevant rules; it does not automatically pay the claim. The Council can adopt, modify, reverse or remand a decision. Its role is not confined to correcting procedural mistakes. CMS appeal-level procedures

Build the evidence packet early

Include the contested determination, relevant medical record, precise reason for disagreement and applicable authority. Organize the clinical timeline so a reviewer can locate the evidence rather than search an unexplained chart dump. CDI can help identify the documentation and clinical issues; authorized appeals staff, clinicians and counsel address their respective responsibilities.

For a provider or supplier appealing a Part A/B QIC reconsideration, new evidence first offered at OMHA is subject to a good-cause requirement. Explain and substantiate why it was not submitted earlier. Examples include a material issue first raised by the QIC or documented unsuccessful reasonable attempts to obtain the evidence. This is not a blanket ban on all later argument or all evidence from every participant: the rules distinguish documentary evidence, oral testimony, unrepresented beneficiaries and other specified parties. A position paper discussing evidence already in the record is different from newly introduced medical evidence. OMHA Case Processing Manual, Chapter 10, §§10.4.4 and 10.5

Worked decision: A hospital receives a QIC denial and finds an omitted laboratory report in its own file. The best response is to assess the new-evidence rule and provide a truthful, supported explanation with the OMHA request. It should not assume that calling the report an “appeal attachment” makes it admissible, or that later testimony automatically cures the omission. Preserve submission receipts and the original record; never backdate documentation to improve an appeal.